775 results on '"Siest, Gérard"'
Search Results
102. CYP 2C19 and UDP-glucuronosyltransferases not only for drugs but also for endobiotics
103. The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study.
104. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids
105. Influence of Genetic Variations on Levels of Inflammatory Markers of Healthy Subjects at Baseline and One Week after Clopidogrel Therapy; Results of a Preliminary Study
106. Pharmacogenomics: from cell to clinic
107. A prospective study on the prevalence of metabolic syndrome among healthy french families: two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-alpha) are revealed in the offspring of parents with metabolic syndrome.
108. Clinical Chemistry and Laboratory Medicine: progress and new challenges for our 50-year-old journal
109. Drug Metabolism and Drug Interactions and the European Society of Pharmacogenomics and Theranostics
110. High Prevalence of Metabolic Syndrome in Iran in Comparison with France: What Are the Components That Explain This?
111. A Genome-Wide Association Study Identifies rs2000999 as a Strong Genetic Determinant of Circulating Haptoglobin Levels
112. Maintain the goals of Drug Metabolism and Drug Interactions
113. Alcohol Consumption, Beverage Preference, and Diet in Middle-Aged Men from the STANISLAS Study
114. Pharmacogenomics and drug interactions. A specific journal
115. Metabolic syndrome-related composite factors over 5years in the STANISLAS Family Study: Genetic heritability and common environmental influences
116. Sex‐dependent Associations of Leptin With Metabolic Syndrome–related Variables: The Stanislas Study
117. Segregation analysis and variance components analysis of bone mineral density in healthy families
118. Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology
119. Frequency and effects of the apolipoprotein A-IV polymorphism
120. DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population
121. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
122. Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable results
123. Effect of HMGCoA Reductase Inhibitors on Cytochrome P450 Expression in Endothelial Cell Line
124. Variations pré-analytiques des biomarqueursprotéiques
125. Meeting Report: From human genetic variations to prediction of risks and responses to drugs and the environment
126. Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort
127. Genetic determinants of blood pressure regulation
128. Biological variations, genetic polymorphisms and familial resemblance of TNF-α and IL-6 concentrations: STANISLAS cohort
129. Genetic influences on blood pressure within the Stanislas Cohort
130. Synthesis and in Vitro Antioxidant Activity of Glycyrrhetinic Acid Derivatives Tested with the Cytochrome P450/NADPH System
131. Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study
132. Changes in Serum Retinol, α-Tocopherol, Vitamin C, Carotenoids, Zinc and Selenium after Micronutrient Supplementation during Alcohol Rehabilitation
133. Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort
134. Editorial
135. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe
136. Extension of variance components approach to incorporate temporal trends and longitudinal pedigree data analysis
137. Apolipoprotein E in Apolipoprotein B (apo B)- and Non-apo B-containing Lipoproteins in 3523 Participants in the Stanislas Cohort: Biological Variation and Genotype-specific Reference Limits
138. Editorial
139. Growing Significance of Myeloperoxidase in Non-infectious Diseases
140. Serum Total Antioxidant Status Is Higher in Postmenopausal Women and after Estrogen Replacement Therapy
141. Family Studies: Their Role in the Evaluation of Genetic Cardiovascular Risk Factors
142. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms
143. Soluble Transferrin Receptor (sTfR): Biological Variations and Reference Limits
144. High Sensitivity C-Reactive Protein (CRP) Reference Intervals in the Elderly
145. Editorial
146. Candidate Gene Polymorphism in Cardiovascular Disease: A Comparative Study of Frequencies between a French and an Italian Population
147. Determination of Serum Cystatin C: Biological Variation and Reference Values
148. Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort
149. High Sensitivity C-Reactive Protein: Biological Variations and Reference Limits
150. Familial Studies on the Genetics of Cardiovascular Diseases: the Stanislas Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.